Harte-Hanks (NASDAQ: HHS) reported Q2 EPS of ($3.84), $3.91 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $45.03 million versus the consensus estimate of $47.5 million.

For earnings history and earnings-related data on Harte-Hanks (HHS) click here.